One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Classification of Microarray ChipsJanuary 20, 2023A biochip or microarray chip is a microscope slide for the laboratory, usually made of silicon chip, glass, nylon film. It is usually a 2D array (sometimes 3D) with thousands of microwells at defined ...view
What Is The Test For Alcohol Metabolite?March 11, 2024In the realm of diagnostic testing, understanding the body’s processing of substances such as alcohol is crucial for a myriad of applications, from clinical diagnostics to forensic analysis. CapitalB...view
A Deep Dive into CapitalBiotech's LuxScan TechnologyFebruary 8, 2024Microarrays have revolutionized the field of life sciences, enabling researchers to analyze thousands of genes simultaneously. This technology underpins advancements in various fields, from drug disco...view
Decoding Genomic Medicine: The Power of Clinical WES in Patient CareJanuary 4, 2024In recent years, genomic medicine has revolutionized the way healthcare professionals diagnose and treat various diseases. A key component of this approach is Clinical WES (Whole Exome Sequencing), wh...view